Donald A Denkhaus - Net Worth and Insider Trading
Donald A Denkhaus Net Worth
The estimated net worth of Donald A Denkhaus is at least $7 Million dollars as of 2024-11-10. Donald A Denkhaus is the Director of Catalyst Pharmaceuticals Inc and owns about 277,666 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $7 Million. Details can be seen in Donald A Denkhaus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Donald A Denkhaus has not made any transactions after 2022-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Donald A Denkhaus
Donald A Denkhaus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Donald A Denkhaus owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Donald A Denkhaus’s form 4 insider trades.
Insider Ownership Summary of Donald A Denkhaus
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | director |
Donald A Denkhaus Latest Holdings Summary
Donald A Denkhaus currently owns a total of 1 stock. Donald A Denkhaus owns 277,666 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 11, 2022, with a value of $7 Million.
Latest Holdings of Donald A Denkhaus
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | 277,666 | 23.93 | 6,644,547 |
Holding Weightings of Donald A Denkhaus
Donald A Denkhaus Form 4 Trading Tracker
According to the SEC Form 4 filings, Donald A Denkhaus has made a total of 2 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 20,000 shares on November 11, 2022, which brought Donald A Denkhaus around $331,800.
Insider Trading History of Donald A Denkhaus
- 1
Donald A Denkhaus Trading Performance
GuruFocus tracks the stock performance after each of Donald A Denkhaus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald A Denkhaus is 31.14%. GuruFocus also compares Donald A Denkhaus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald A Denkhaus within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Donald A Denkhaus's insider trading performs compared to the benchmark.
Performance of Donald A Denkhaus
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.22 | | | | | |
| Relative Return to S&P 500(%) | 3.05 | | | | | |
Donald A Denkhaus Ownership Network
Ownership Network List of Donald A Denkhaus
Ownership Network Relation of Donald A Denkhaus
Donald A Denkhaus Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Donald A Denkhaus is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Donald A Denkhaus made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Donald A Denkhaus Mailing Address
Above is the net worth, insider trading, and ownership report for Donald A Denkhaus. You might contact Donald A Denkhaus via mailing address: 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
